An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions.

Akay, Melek; Funingana, Ionut-Gabriel; Patel, Grisma; Mustapha, Rami; Gjafa, Ernese; Ng, Tony; Ng, Kenrick; Flynn, Michael J.

Affiliation

Akay M; Department of Medical Oncology, St George's University Hospitals NHS Foundation Trust, London, UK.
Funingana IG; Department of Medical Oncology, University of Cambridge, Cambridge, UK.
Patel G; Department of Medical Oncology, University College London Hospitals, London, UK.
Mustapha R; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Gjafa E; Cancer Research UK King's Health Partners Centre, London, UK.
Ng T; Department of Medical Oncology, Barts Health NHS Trust, London, UK.
Ng K; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Flynn MJ; Cancer Research UK King's Health Partners Centre, London, UK.

Oncol Ther ; 9(2): 347-364, 2021 Dec.

Article in En | MEDLINE | ID: mdl-34363200